Programme

Timings are in Eastern Standard Time (EST) and to view the event start time in your local time zone, please click here.

  1. Welcome and introduction

    by the conference moderator 

    Vanessa Zainzinger Vanessa Zainzinger
    Senior Reporter, Chemical Watch
  2. Session 1: Office of Pesticide Programs (OPP) priorities and challenges
  3. EPA’s Antimicrobial Division’s 2022 accomplishments, and priorities for 2023

    Lisa Christ, Associate Director, Antimicrobials Division, EPA

  4. Industry response to the next phase of the EPA’s Registration Review Program

    • Current state of the EPA’s Registration Review Program 
      • current timetable
      • types of response  
    • Industry response to the EPA’s interim decision (ID)/proposed interim decision (PID) actions 
      • aside from shock…… 
      • initial approach  
    • Looming Registration Review concerns
      • after responding to a PID what happens?
      • response timing
      • Endangered Species Act (ESA)/endocrine disruptor (ED) concerns 
    Adrian Krygsman Adrian Krygsman
    Director, Troy Corporation an Arxada Company
  5. Emerging Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) legal and policy issues and the Congress: Implications for the pesticide community

    Meibao Zhuang, Senior Regulatory Consultant, Bergeson and Campbell PC and  

    Dennis Deziel, Senior Government Affairs Advisor, Bergeson and Campbell PC 

  6. Q&A and panel discussion

  7. Refreshment break

  8. Session 2: Updates on Endangered Species Act (ESA) and other federal/state level developments
  9. Endangered species screen and implications of registration

    Charles (Chuck) Peck Charles (Chuck) Peck
    Senior Fate Scientist, Office of Pesticide Programs’ Antimicrobials Division, EPA
  10. Navigating electronic Confidential Statement of Formula (eSCFs) for biocide registrations

    • History of eCSFs 
    • Overview of CDX process for creating/editing eCSFs 
    • Benefits 
    • Challenges 
    • Summary 
    Lisa Amadio Lisa Amadio
    Principal, Ramboll
  11. Upcoming smart label introduction and challenges: impact to registrants and the marketplace

    Hal Ambuter, VP, Regulatory & Government Affairs, Reckitt 

  12. PFAS state by state regulation: Impact on pesticide packaging

    • Introduction 
    • State PFAS regulations and their impact on pesticides and pesticide packaging
      • adopted
      • introduced
    • Compliance strategy
    Jamie Venable Jamie Venable
    Senior Consultant, Scientific & Regulatory Consultants
  13. Q&A

  14. Lunch

  15. Session 3: Latest efficacy developments
  16. Interim guidance to support porous claims 

    James Tauber James Tauber
    Microbiologist, EPA
  17. Emerging viral pathogens guidance

    Tajah Blackburn Tajah Blackburn
    Senior Scientist, EPA
  18. Surface coatings: changes to current testing methodologies and finalised testing guidelines

    • Changes in US residual testing guidance for coatings for public health use
      • residual self sanitization (“RSS”)
      • residual self-disinfection (“RSD”)
      • supplemental residual coatings/fixed items 
    • Other residual methods for non-public health claims 
    • Residual testing methods under development 
    Rhonda Jones Rhonda Jones
    Chief Executive Officer, Scientific & Regulatory Consultants
  19. New testing protocols for air sanitisation

    Diane Boesenberg Diane Boesenberg
    Senior Managing Scientist, Exponent
  20. Q&A

  21. Refreshment break

  22. Session 4: Canada – trends and updates
  23. Proposed draft regulation to change the regulatory framework for biocides in Canada

    Bio Aikawa, Director,Bureau of Product Review and Assessment (BPRA), Natural and Non-prescription Health Products Directorate (NNHPD), Health Canada

  24. Industry concerns with the Canadian PMRA’s transformation process

    • Status of the transformation process
      • process changes 
      • continuous oversight/technology revisions
      • transparency  
    • Implementation schedule and perception  
      • 2023 Implementation 
      • effect on re-evaluation process 
      • gaps 
    Adrian Krygsman Adrian Krygsman
    Director, Troy Corporation an Arxada Company
  25. Q&A and final panel discussion

  26. End of conference